CTSC KL2 Program
The NIH-funded CTSC supports highly qualified junior faculty to conduct mentored, multidisciplinary, patient-oriented clinical research. Clinical research is defined as (a) patient oriented research conducted with human subjects (or on material of human origin) that includes mechanisms of human disease, therapeutic interventions, clinical trials, and/or development of new technologies; (b) epidemiologic and behavioral studies; (c) health services and outcomes research. The period of support is for 2 years but may extend for up to 3 years.
The goal of the program is to accelerate the career development of promising junior faculty, promoting their development as independent clinical multidisciplinary research investigators. The program will provide selected scholars with a salary of $110,000 plus benefits (up to $145,090 in salary and benefits combined), as well as $25,000 for travel and research expenses each year. Travel to the annual CTSA Translational Science meeting is mandatory in the first two years, and submission of an abstract is required for reimbursement of travel expenses, and submission of an abstract is required for reimbursement of travel expenses. Scholars in the KL2 program will:
- Obtain additional research training through participation in coursework, workshops, and/or individualized programs of study.
- Conduct a rigorous multidisciplinary clinical/patient-oriented research investigation relevant to their research interests.
- Be mentored by senior investigators from diverse backgrounds with a demonstrated track record of successfully developing the careers of junior colleagues.
- Utilize, and participate in, the activities and resources of the UC Davis CTSC, as well as a nation-wide consortium of 60 other NIH-funded CTSA sites. This will include a commitment to presenting their research progress at meetings and in seminars.
Stephanie Crossen, an assistant professor of pediatrics and a Clinical and Translational Science Center KL2 scholar, received the Judges’ Award for her exceptional presentation on the use of home-based telemedicine to improve care delivery for pediatric patients with poorly controlled Type 1 diabetes. She was recognized at the Society for Education and the Advancement of Research in Connected Health‘s Telehealth Research Symposium in San Diego Oct. 24.